NCT07767227 · Translational Genomics Research Institute
Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts
What this study is about
The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.
View original scientific description
The goal of this study is to collect biospecimens (blood and cystic fluid) and data from participants who have a pancreatic cyst that requires surgical resection. The blood and fluid samples will be analyzed for research into DNA, RNA, and proteins.
Primary outcome measures
Characterize the miRNA and protein signatures in exosomes derived from blood and cyst fluids in patients with worrisome cystic pancreatic tumors
Time frame: At enrollment
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Voluntarily agree to participate by giving written informed consent prior to any study-specific procedures.
- Subject at least 18 years of age and able to provide consent. Subject is willing and able to comply with requirements of the protocol.
- Radiologically documented cyst of the pancreas for which surgical removal is clinically indicated.
- Patient will be undergoing a surgical resection of their pancreatic cystic neoplasm.
Exclusion criteria
- Patient who is pregnant at the time of study enrollment and sample collection.
- Patient will not be undergoing clinically indicated surgery for a pancreatic cystic neoplasm.
- Patient is unwilling or unable to provide informed consent or comply with study procedures.
Where
- Newport Beach, California
- Atlanta, Georgia
Collaborators
Hoag Memorial Hospital Presbyterian, City of Hope National Medical Center, Piedmont Healthcare
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 17, 2026 · Source of record for eligibility and locations